Page 1 of Clinical Trials for Drug abraxane, 1751 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Single Agent Abraxane as Second Line Therapy in Bladder Cancer
Last Updated: July 19, 2011
Condition(s): Transitional Cell Carcinoma
2
Active, not recruiting
A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
Last Updated: May 11, 2012
Condition(s): Malignant Melanoma
3
Active, not recruiting
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
Last Updated: February 14, 2012
Condition(s): Solid Tumors
4
Active, not recruiting
A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen
Last Updated: May 17, 2012
Condition(s): Cancer
5
Not yet recruiting
Balloon Elution and Late Loss Optimization (BELLO) Study
Last Updated: March 23, 2010
Condition(s): Coronary Artery Disease
6
Active, not recruiting
A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPARγ Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy
Last Updated: August 29, 2011
Condition(s): Anaplastic Thyroid Cancer
7
Not yet recruiting
A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
Last Updated: March 14, 2012
Condition(s): Breast Cancer; Lung Cancer; Renal Cancer; Adrenal Cancer
8
Recruiting
Oral Azacitidine as a Single Agent and in Combination With Carboplatin or Abraxane® in Subjects With Relapsed or Refractory Solid Tumors
Last Updated: April 20, 2012
Condition(s): Relapsed or Refractory Solid Tumors
9
Recruiting
Central European Society for Anticancer Research (CESAR) Study of Paclitaxel Therapeutic Drug Monitoring
Last Updated: March 30, 2011
Condition(s): Carcinoma, Non-Small-Cell Lung
10
Active, not recruiting
Treatment of Drug-eluting Stent (DES) In-Stent Restenosis With SeQuent® Please Paclitaxel Eluting Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter
Last Updated: May 19, 2011
Condition(s): In-Stent Restenosis
11
Recruiting
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
Last Updated: June 23, 2011
Condition(s): In-stent Restenosis
12
Completed
Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals
Last Updated: June 23, 2005
Condition(s): Sarcoma, Kaposi; HIV Infections
13
Not yet recruiting
A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation
Last Updated: May 15, 2012
Condition(s): Breast Cancer
14
Recruiting
Optical Coherence Tomography for Drug Eluting Stent Safety
Last Updated: June 5, 2008
Condition(s): Coronary Artery Disease
15
Recruiting
Chemotherapeutic Agents in Brain/Breast
Last Updated: May 11, 2012
Condition(s): Breast Cancer; Metastatic Cancer
16
Active, not recruiting
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
Last Updated: December 13, 2011
Condition(s): Chemotherapeutic Agent Toxicity; Fallopian Tube Cancer; Neurotoxicity; Ovarian Cancer; Pain; Peripheral Neuropathy; Primary Peritoneal Cavity Cancer
17
Active, not recruiting
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients
Last Updated: May 23, 2012
Condition(s): Breast Cancer Female
18
Recruiting
Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer
Last Updated: July 19, 2011
Condition(s): Non-small Cell Lung Cancer
19
Completed
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
Last Updated: May 9, 2009
Condition(s): Drug/Agent Toxicity by Tissue/Organ; Hemoptysis; Lung Cancer
20
Completed
A Trial Comparing a Paclitaxel Eluting Stent With Biodegradable Polymer Versus a Bare Metal Stent
Last Updated: May 27, 2010
Condition(s): Coronary Artery Disease

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+abraxane

Page 1 of Clinical Trials for Drug abraxane, 1751 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About